Aktiesnakken — December 2009
-
det er derfor tror jeg, at vi lige har fået underskrift fra alpco,
-
det er ikke kamp med abbott, den licens kunne blive underskrevet imorgen, hvis bioporto vil.. (Min konklusion, jvf. seneste indlæg)
-
de firmaer er der jo nok af i usa,
-
et succesfyldt samarbejde med alpco, kan vel financiere bioporto, sålænge vi undgår store uforudsete
-
var det noget med 3 gange mistet indtjening for abbott, da de tabte den sag, gav det desvimlende summer
... patentrettighederne og viden er ikke optaget til nogen værdi
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind